Anti-p16-INK4a Antibody, clone 5F22 Antibody, ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 5F22 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Cyclin-dependent kinase inhibitor 2A (p16-INK4a). It targets an epitope within the first 54 amino acids from the N-terminal.
• Immunogen: GST/His-tagged recombinant fragment corresponding to the first 54 amino acids from human Cyclin-dependent kinase inhibitor 2A (p16-INK4a).
• Application: Anti-p16-INK4a, clone 5F22, ZooMAb, Cat. No. ZRB1437, is a recombinant Rabbit monoclonal antibody that specifically targets p16-INK4a and is tested in Affinity Binding Assay, Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
• Target description: Cyclin-dependent kinase inhibitor 2A (UniProt: P42771; also known as Cyclin-dependent kinase 4 inhibitor A, CDK4I, Multiple tumor suppressor 1, MTS-1, p16-INK4a, p16-INK4, p16INK4A) is encoded by the CDKN2A (also known as CDKN2, MTS1) gene (Gene ID: 1029) in human. p16-INK4 is a widely distributed protein that acts as a negative regulator of proliferation of normal cells. It is reported to be the principal member of the IINK4 family of CDK inhibitors. It heterodimerizes with CDK4 or CDK6 and inhibits their ability to interact with cyclin D and to phosphorylate the retinoblastoma protein. It is considered a tumor suppressor protein because of physiological role and down-regulated expression in a large number of tumors. Overexpression of p16-INK4a has also been described in several tumors, including endometrial, colorectal and basal cell carcinoma. Six isoforms of p16-INK4a have been described that are produced by alternative splicing. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 0.3 mg/mL after reconstitution at 25μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommended storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.